Sage Mountain Advisors LLC Edwards Lifesciences Corp Transaction History

Sage Mountain Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$84.3 - $94.31 $240,170 - $268,689	2,849 New	2,849 $263,000
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $2,549 - $3,208	25 Added 0.89%	2,844 $335,000
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $16,806 - $20,647	158 Added 5.94%	2,819 $365,000
Q2 2021 Jul 22, 2021	BUY	$83.84 - $104.76 $19,618 - $24,513	234 Added 9.64%	2,661 $276,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $1,416 - $1,632	18 Added 0.75%	2,427 $203,000
Q4 2020 Jan 21, 2021	BUY	$71.69 - $91.23 $172,701 - $219,773	2,409 New	2,409 $220,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sage Mountain Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Sage Mountain Advisors LLC with notifications on news.